ERDAFITINIB treats bladder cancer and kidney cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

With the Patient Assistance Program from Johnson & Johnson Patient Assistance Foundation, Inc., if you meet program requirements and are approved, you’ll receive your medication for up to one year.